Showing results (281-290 of 548) with videos related to

Sort By:
Pageof 55
The Journal of Investigative Dermatology|October 20, 2019
Development, Validation, and Interpretation of the PROMIS Itch Questionnaire: A Patient-Reported Outcome Measure for the Quality of Life Impact of ItchJonathan I Silverberg, Jin-Shei Lai, Robert W Kantor, et al.
Acta Dermato-Venereologica|April 8, 2022
Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic DermatitisAndreas Wollenberg, Danielle Marcoux, Jonathan I Silverberg, et al.
Contact Dermatitis|May 16, 2025
Burden of Pain and Use of Analgesics in Patients With Chronic Hand Eczema-Findings From the Danish Skin CohortJeanette Halskou Haugaard, Johan Sieborg, Emma Guttman-Yassky, et al.
Scientific Reports|April 17, 2024
Interventions for anxiety and depression in patients with atopic dermatitis: a systematic review and meta-analysisStella P Hartono, Sheena Chatrath, Ozge N Aktas, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 21, 2019
A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD): Baseline treatment patterns and unmet needs assessmentWenhui Wei, Eric Ghorayeb, Michael Andria, et al.
The Journal of Allergy and Clinical Immunology|June 16, 2018
Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAbAndreas Wollenberg, Michael D Howell, Emma Guttman-Yassky, et al.
The British Journal of Dermatology|February 10, 2023
Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3Kristian Reich, Eric Simpson, Andreas Wollenberg, et al.
Dermatology and Therapy|June 19, 2024
Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic DermatitisApril W Armstrong, Andrew F Alexis, Andrew Blauvelt, et al.
The Journal of Dermatological Treatment|September 11, 2023
Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis RegistryJonathan I Silverberg, Evangeline Pierce, Meghan Feely, et al.
International Journal of Medical Sciences|July 9, 2009
Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case reportMartin H Bluth, Stephan Kohlhoff, Kevin B Norowitz, et al.
Pageof 55